A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
Source:
wired
September 30, 2026 · 07:30
From the publisher
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
The original article opens on the publisher's website.
More from General
View topic →Seth Meyers on Trump canceling $1bn in federal funds: ‘Is he adding a waterslide to the reflecting pool?’
guardianTech
Sep 30, 2026 · 08:46
E.E.O.C. Sues Harvard for Data on Diversity in Hiring Practices
nytimes
Sep 30, 2026 · 08:38
Open USD takes on Tether, Circle with a different stablecoin model that's 'building money'
coinDesk
Sep 30, 2026 · 08:34
How Ukrainians are coping with new, more deadly Russian attacks
nprNews
Sep 30, 2026 · 08:33
How will Trump ‘accord’ for AI to ‘self-regulate’ work?
financialTimes
Sep 30, 2026 · 08:31